Welcome to our dedicated page for Priveterra Acquisition II news (Ticker: PMGM), a resource for investors and traders seeking the latest updates and insights on Priveterra Acquisition II stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Priveterra Acquisition II's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Priveterra Acquisition II's position in the market.
Priveterra Acquisition Corp. II (NASDAQ: PMGMU, PMGM, PMGMW) received a notice from Nasdaq due to the late filing of its Annual Report on Form 10-K for the period ended December 31, 2023. The delinquency may lead to delisting of the Company's securities from Nasdaq, and the Nasdaq Hearings Panel will review the matter. The Company must submit its views in writing by May 6, 2024.
Summary not available.
Summary not available.
Summary not available.
AEON Biopharma, a clinical-stage biopharmaceutical company, and Priveterra Acquisition Corp. (NASDAQ: PMGM) have filed a Form S-4 with the SEC related to their proposed merger. This merger aims to make AEON a publicly traded entity, enhancing its development of ABP-450, a proprietary botulinum toxin aimed at treating debilitating medical conditions. The merger is expected to close in the first half of 2023, pending shareholder approval and the satisfaction of customary closing conditions.
FAQ
What is the current stock price of Priveterra Acquisition II (PMGM)?
What is the market cap of Priveterra Acquisition II (PMGM)?
